Document is current
Any future updates will be listed below
-
Authors
Yoon, Soo-Young
Park, Hye Won
Kim, Hyeon Jin
Kronbichler, Andreas
Koyanagi, Ai
Smith, Lee
Shin, Jae Il
Rhee, Sang Youl
Lee, Seung Won
Kim, Jin Sug
Hwang, Hyeon Seok
Yon, Dong Keon
Jeong, Kyunghwan
- License Information
-
More Information
Article History
Received: 9 January 2023
Accepted: 7 April 2023
First Online: 10 April 2023
Competing interests
: AnK has received consultancy fees from Vifor Pharma, Otsuka, Walden Biosciences, Catalyst Biosciences, and Delta 4. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All the other authors declared no competing interests.
